Enterisol® Ileitis - the new live oral vaccine for porcine ileitis from Boehringer Ingelheim

The information below is presented by ThePigSite.com on behalf of Boehringer Ingelheim.
If you wish to contact Boehringer Ingelheim you can do so by visiting their contact page


Ileitis information for Germany Ileitis information for Spain Ileitis information for Belgium Ileitis information for Netherlands "Enterisol Happy Pigs" song	Contact Boehringer Products Ileitis home ENTERISOL® ILEITIS INGELVAC® M.HYO INGELVAC® PRRS KV METACAM tm ENTERISOL® ILEITIS Enterisol® Ileitis: the first and only vaccine for the control of Porcine Proliferative Enteropathy. Benefits of Enterisol Ileitis Enterisol® Ileitis provides active immunity against the damages caused by Lawsonia intracellularis infection. Enterisol® Ileitis improves weight gain Enterisol® Ileitis reduces body weight variability Enterisol® Ileitis protects against diarrhea and mortality associated with Ileitis Enterisol® Ileitis can contribute to reduce the total antimicrobial use in pig farms Click here to download our comprehensive product data sheet. Latest News and Features Ileitis Symposium during the IPVS in Copenhagen COPENHAGEN - Boehringer Ingelheim is proud to announce the 2nd Boehringer Ingelheim IPVS Ileitis symposium during the IPVS 2006 congress in Copenhagen.... Enterisol® Ileitis approved in Australia - first live swine vaccine ever in this market AUSTRALIA - Boehringer Ingelheim Animal Health GmbH, announced today that the Australian regulatory authorities have granted market authorization for the porcine live vaccine Enterisol® Ileitis. Enterisol®... Swine practice: Marked increase in performance after ileitis vaccination EU - Since the launch of Boehringer's ileitis vaccine "Enterisol® Ileitis" in most European countries from September to November 2005, the oral ileitis vaccine has very quickly become firmly established... First vaccine for the control of porcine Ileitis now available across Europe GERMANY - Boehringer Ingelheim Animal Health GmbH, have announced the pan-European launch of Enterisol® Ileitis, the first enteric vaccine to have received marketing authorization in the EU to improve... Economic Impact of Enterisol® Ileitis in Clinical and Subclinical Herds By M. Adam, Boehringer Ingelheim Animal Health GmbH, Ingelheim, Germany. Worldwide, ileitis is prevalent in 3 forms: acute, chronic and subclinical.... Field Experiment with Enterisol® Ileitis in Spain By José Luis Lorenzo and Mª Luisa Rosas of MAPORC S.C. Segovia. Ileitis is a very common disease, and its prevalence is very high on most farms in Spain.... Ileitis Treatments Comparison: Oral Vaccination V's antibiotics By M. Y. C. Thaker and G. Bilkei - Comparison of the effects of oral vaccination and different antibiotic prophylactic treatments against Lawsonia intracellularis associated losses in a finishing pig unit... Vaccinated pigs grow bigger and generate more profit! By Harm Voets, DVM, Boehringer Ingelheim Animal Health GmbH, Germany - as presented at the Proceedings of the European Press Meeting on Ileitis, June 13 2006, Ingelheim. Mass vaccination of swine populations... TO RECEIVE FURTHER INFORMATION ON ENTERISOL ILEITIS PLEASE DO SO BY CONTACTING US HERE
Boehringer Ingelheim Animal Health GmbH, 55216 Ingelheim, Germany. www.boehringer-ingelheim.com

Other Web Sites
	ThePoultrySite
	TheFishSite
	TheBioenergySite
	TheCattleSite
	TheBeefSite
	TheDairySite

	ThePigSite.cn
	ThePoultrySite.cn
	TheFishSite.cn

Tuesday 2nd December